World Library  
Flag as Inappropriate
Email this Article

Antiarrhythmic agents

Article Id: WHEBN0000789530
Reproduction Date:

Title: Antiarrhythmic agents  
Author: World Heritage Encyclopedia
Language: English
Subject: Ventricular fibrillation, Dofetilide, Quinidine, Amiodarone, Cardiac action potential, Interstitial lung disease, Grapefruit–drug interactions, Lorcainide, D. George Wyse
Publisher: World Heritage Encyclopedia

Antiarrhythmic agents

Antiarrhythmic agents are a group of pharmaceuticals that are used to suppress abnormal rhythms of the heart (cardiac arrhythmias), such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation.

Many attempts have been made to classify antiarrhythmic agents. The problem arises from the fact that many of the antiarrhythmic agents have multiple modes of action, making any classification imprecise.

According to at least one source, cardiac anti-arrhythmia drugs have "cost more American lives than the Vietnam War".[1]

Singh Vaughan Williams classification

The Singh Vaughan Williams classification, introduced in 1970 based on the seminal work of Bramah N. Singh in his doctoral thesis at Oxford where Vaughan Williams was his advisor and on subsequent work by Singh and his colleagues in the United States, is one of the most widely used classification schemes for antiarrhythmic agents. This scheme classifies a drug based on the primary mechanism of its antiarrhythmic effect. However, its dependence on primary mechanism is one of the limitations of the Singh-VW classification, since many antiarrhythmic agents have multiple action mechanisms. Amiodarone, for example, has effects consistent with all of the first four classes. Another limitation is the lack of consideration within the Singh-VW classification system for the effects of drug metabolites. Procainamide—a class Ia agent whose metabolite N-acetyl procainamide (NAPA) has a class III action—is one such example. A historical limitation was that drugs such as digoxin and adenosine – important antiarrhythmic agents – had no place at all in the VW classification system. This has since been rectified by the inclusion of class V.

With regards to management of atrial fibrillation, Class I and III are used in rhythm control as medical cardioversion agents whilst Class II and IV are used as rate control agents.

There are five main classes in the Singh Vaughan Williams classification of antiarrhythmic agents:

Overview table

Class Known as Examples Mechanism Clinical uses in cardiology [2]
Ia fast-channel blockers-affect QRS complex (Na+) channel block (intermediate association/dissociation)
Ib Do not affect QRS complex (Na+) channel block (fast association/dissociation)
Ic (Na+) channel block (slow association/dissociation)
II Beta-blockers beta blocking
Propranolol also shows some class I action
III K+ channel blocker

Sotalol is also a beta blocker[3] Amiodarone has Class I, II, III & IV activity

IV slow-channel blockers Ca2+ channel blocker
V Work by other or unknown mechanisms (Direct nodal inhibition). Used in supraventricular arrhythmias, especially in Heart Failure with Atrial Fibrillation, contraindicated in ventricular arrhythmias. Or in the case of Magnesium Sulfate, used in Torsades de Pointes.

Class I agents

The class I antiarrhythmic agents interfere with the sodium channel. Class I agents are grouped by what effect they have on the Na+ channel, and what effect they have on cardiac action potentials.

Class I agents are called Membrane Stabilizing agents. The 'stabilizing' word is used to describe the decrease of excitogenicity of the plasma membrane which is brought about by these agents. (Also noteworthy is that a few class II agents like propranolol also have a membrane stabilizing effect.)

Class I agents are divided into three groups (Ia, Ib and Ic) based upon their effect on the length of the action potential.[4][5]

  • Ia lengthens the action potential (right shift)
  • Ib shortens the action potential (left shift)
  • Ic does not significantly affect the action potential (no shift)

There is a popular mnemonic to remember the class I agents:

Class Ia Disopyramide, Quinidine, Procainamide Double Quarter Pounder

Police Department Questions (Procainamide, Disopyramide, Quinidine)

Class Ib Lidocaine, Mexiletine, Tocainide Lettuce, Mayo, Tomato

The Little Man (Tocainide, Lidocaine, Mexiletine)

Class Ic Moricizine, Flecainide, Propafenone More Fries Please. (note there are two "M"s in the mnemonic, but moricizine and more can clarify which is which)

For Pushing Ecstasy (Molly or Ecstasy may be used to denote Moricizine or Encainide)

Class II agents

Class II agents are conventional beta blockers. They act by blocking the effects of catecholamines at the β1-adrenergic receptors, thereby decreasing sympathetic activity on the heart. These agents are particularly useful in the treatment of supraventricular tachycardias. They decrease conduction through the AV node.

Class II agents include atenolol, esmolol, propranolol, and metoprolol.

Class III agents

Class III agents predominantly block the potassium channels, thereby prolonging repolarization.[6] Since these agents do not affect the sodium channel, conduction velocity is not decreased. The prolongation of the action potential duration and refractory period, combined with the maintenance of normal conduction velocity, prevent re-entrant arrhythmias. (The re-entrant rhythm is less likely to interact with tissue that has become refractory). Drugs include: bretylium, amiodarone, ibutilide, sotalol, dofetilide, and dronedarone. Inhibiting potassium channels, slowing repolarization, results in slowed atrial-ventricular myocyte repolarization. Class III agents have the potential to prolong the QT interval of the EKG.

Class IV agents

Class IV agents are slow calcium channel blockers. They decrease conduction through the AV node, and shorten phase two (the plateau) of the cardiac action potential. They thus reduce the contractility of the heart, so may be inappropriate in heart failure. However, in contrast to beta blockers, they allow the body to retain adrenergic control of heart rate and contractility.

Class IV agents include verapamil and diltiazem.

Other agents ("Class V")

Since the development of the original Vaughan-Williams classification system, additional agents have been used that don't fit cleanly into categories I through IV.

Some sources use the term "Class V".[7] However, they are more frequently identified by their precise mechanism.

Agents include:

Sicilian Gambit classification

Another approach, known as the "Sicilian Gambit", placed a greater approach on the underlying mechanism.[12][13][14]

It presents the drugs on two axes, instead of one, and is presented in tabular form. On the Y axis, each drug is listed, in approximately the Vaughan Williams order. On the X axis, the channels, receptors, pumps, and clinical effects are listed for each drug, with the results listed in a grid. It is therefore not a true classification in that it does not aggregate drugs into categories.[15]

See also


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.